Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Jiaming Che is a leading thoracic surgeon whose research focuses on advancing minimally invasive surgical techniques for lung and esophageal cancers. His major contributions center on rigorously comparing robotic-assisted lobectomy (RAL) with video-assisted thoracoscopic lobectomy (VAL) for non-small-cell lung cancer (NSCLC). His 2021 study, with 116 citations, provided critical early evidence on perioperative outcomes and long-term efficacy. Dr. Che further solidified his impact through a 2019 propensity score-matched study on Ivor Lewis esophagectomy (83 citations) and, most notably, as the lead author of the landmark RVlob randomized controlled trial (2024). This pivotal trial, which directly compared RAL and VAL in a randomized setting, represents a gold-standard contribution to the field, offering definitive data on survival and recovery. With cumulative citations exceeding 218, Dr. Che’s work is essential reading for surgeons and researchers seeking evidence-based guidance on the optimal approach to thoracic oncology surgery.